CDKN2A and liver cancer: In the data on to 371 patients with liver cancer downloaded by TCGA, the patients were divided into CDKN2A high expression (N=232) group and CDKN2A low expression (N=139) group with the median expression of CDKN2A mRNA as the segmentation point (Clinical database sorting from TCGA database).